Data Science in Oncology and Immunology: Drug Design and Target Identification

From Innovation Innovation Communication March 8th, 2021

77 plays You unliked the media.

This session was part of Engage 2020, Princeton University's innovation and entrepreneurship conference.

This session, focusing on Drug Design and Target Identification, was part of a full-day workshop on Data Science in Oncology & Immunology hosted by Princeton University Professor of Computer Science Ben Raphael, Princeton University Professor of Physics Curtis Callen, and Vice President Hisham Hamadeh, Global Head of Data Sciences, Genmab Inc. The Workshop brings together industry and academic researchers from biomedical data science, computational oncology, and computational immunology. It was be held on November 5, 2020.

November 5 offered four sessions of brief presentations and interactive discussions with leading academic and industry researchers:

10:00-11:20 Drug Design and Target Identification

11:30-12:45 Machine Learning for Revealing Biological Mechanism

1:15-2:30 Biomarkers and Immunotherapy

2:40-4:30 New Frontiers in Biomedical Data Science.

Hosted by Dean R. Edelman, Princeton University Corporate Engagement and Foundation Relations

Date: November 5th, 2020
Speaker: Mona Singh (Princeton), Hisham Hamadeh and Brandon Higgs (Genmab Inc.), Matt Truppo (Janssen BioTherapeutics)
Department: Princeton Innovation
Location: Online
Appears In: Corporate Engagement Research

Related Media

Data Science in Oncology and Immunology: Drug Design and Target Identification

Related Media